Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Jansen-Olliges, L.; Chatterjee, S.; Jia, L.; Stahl, F.; Bär, C. et al.: Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor. In: Cells 12 (2023), Nr. 1, 83. DOI: https://doi.org/10.3390/cells12010083

Event: Veröffentlichung

(where): Hannover

(who): Gottfried Wilhelm Leibniz Universität Hannover

(when): 2023

Event: Veröffentlichung

(where): Hannover

(who): Technische Informationsbibliothek (TIB)

(when): 2023

Creator: Jansen-Olliges, Linda
Chatterjee, Shambhabi
Jia, Lili
Stahl, Frank
Bär, Christian
Stadler, Marc
Surup, Frank
Zeilinger, Carsten

DOI: 10.15488/15700

URN: urn:nbn:de:101:1-2023122101311393024620

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jansen-Olliges, Linda
Chatterjee, Shambhabi
Jia, Lili
Stahl, Frank
Bär, Christian
Stadler, Marc
Surup, Frank
Zeilinger, Carsten
Gottfried Wilhelm Leibniz Universität Hannover
Technische Informationsbibliothek (TIB)

Time of origin

2023

Other Objects (12)

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

ACE2: the molecular doorway to SARS-CoV-2

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

ACE2: the molecular doorway to SARS-CoV-2

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

ACE2: the molecular doorway to SARS-CoV-2

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

ACE2: the molecular doorway to SARS-CoV-2

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

ACE2: the molecular doorway to SARS-CoV-2

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

ACE2: the molecular doorway to SARS-CoV-2

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike

Outsmarting SARS-CoV-2 by empowering a decoy ACE2

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions

Related objects

Reset password